Pyridoxine-dependent epilepsy

The Causes of Epilepsy: Common and Uncommon Causes in Adults and Children

Volumn , Issue , 2011, Pages 237-241

  Gospe, Sidney M ^a  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84906897544     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511921001.035     Document Type: Chapter

References (36)

1. Bankier A, Turner M, Hopkins IJ (1983) Pyridoxine dependent seizures: a wider clinical spectrum. Arch Dis Childh 58:415-18.
2. Bass NE, Wyllie E, Cohen B, Joseph SA (1996) Pyridoxine-dependent epilepsy: the need for repeated pyridoxine trials and the risk of severe electrocerebral suppression with intravenous pyridoxine infusion. J Child Neurol 11:422-4.
3. Basura GJ, Hagland SP, Wiltse AM, Gospe SM Jr. (2009) Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63North American cases submitted to a patient registry. Eur J Pediatr 168:697-704.
4. Baxter P (1999) Epidemiology of pyridoxine dependent and pyridoxine responsive seizures in the UK. Arch Dis Childh 81:431-3.
5. Baxter P (2001) Pyridoxine dependent and pyridoxine responsive seizures. In: Baxter P (ed.) Vitamin Responsive Conditions in Pediatric Neurology. London: MacKeith Press, pp. 109-65.
6. Baxter P, Aicardi J (1999) Neonatal seizures after pyridoxine use. (Letter). Lancet 354:2082-3.
7. Baxter P, Griffiths P, Kelly T, Gardner-Medwin D (1996) Pyridoxine-dependent seizures: demographic, clinical, MRI and psychometric features, and effect of dose on intelligence quotient. Dev Med Child Neurol 38:998-1006.
8. Baynes K, Tomaszewski Farias S, Gospe SM Jr. (2003) Pyridoxine-dependent seizures and cognition in adulthood. Dev Med Child Neurol 45:782-5.
9. Been JV, Bok JA, Andriessen P, Renier WO (2005) Epidemiology of pyridoxinedependent seizures in The Netherlands. Arch Dis Childh 90:1293-6.
10. Bennett CL, Chen Y, Hahn S, Glass IA, Gospe SM Jr. (2009) Prevalence of ALDH7A1 mutations in 18North American pyridoxine-dependent seizure (PDS) patients. Epilepsia 50:1167-75.
11. Bok LA, Struys E, Willemsen MA, Been JV, Jakobs C (2007) Pyridoxine-dependent seizures in Dutch patients: diagnosis by elevated urinary alpha-aminoadipic semialdehyde levels. Arch Dis Childh 92:687-9.
12. Coker S (1992) Postneonatal vitamin B6-dependent epilepsy. Pediatrics 90:221-3.
13. Ebinger M, Schutze C, Konig S (1999) Demographics and diagnosis of pyridoxine-dependent seizures. J Pediatr 134:795-6.
14. Gallagher RC, Van Hove JL, Scharer G (2009) Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy. Ann Neurol 65:550-6.
15. Gospe SM Jr. (1998) Current perspectives on pyridoxine-dependent seizures. J Pediatr 132:919-23.
16. Gospe SM Jr. (2002) Pyridoxine-dependent seizures: findings from recent studies pose new questions. Pediatr Neurol 26:181-5.
17. Gospe SM Jr., Hecht ST (1998) Longitudinal MRI findings in pyridoxine-dependent seizures. Neurology 51:74-8.
18. Goutières F, Aicardi J (1985) Atypical presentations of pyridoxine-dependent seizures: a treatable cause of intractable epilepsy in infants. Ann Neurol 17:117-20.
19. Haenggeli C-A, Girardin E, Paunier L (1991) Pyridoxine-dependent seizures, clinical and therapeutic aspects. Eur J Pediatr 150:452-5.
20. Hoffmann GF, Schmitt B, Windfuhr M (2007) Pyridoxal 50-phosphate may be curative in early-onset epileptic encephalopathy. J Inherit Metab Dis 30:96-9.
21. Hunt AD, Stokes J, McCrory WW, Stroud HH (1954) Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics 13:140-5.
22. Kanno J, Kure S, Narisawa A (2007) Allelic and non-allelic heterogeneities in pyridoxine dependent seizures revealed by ALDH7A1 mutational analysis. Mol Genet Metab 91:384-9.
23. Lott IT, Coulombe T, Di Paolo RV, Richardson EP, Levy HL (1978) Vitamin B6-dependent seizures: pathology and chemical findings in brain. Neurology 28:47-54.
24. McLachlan RS, Brown WF (1995) Pyridoxine-dependent epilepsy with iatrogenic sensory neuronopathy. Can J Neurol Sci 22:50-1.
25. Mikati MA, Trevathan E, Krishnamoorthy KS (1991) Pyridoxine-dependent epilepsy: EEG investigation and long-term follow-up. Electroencephalogn Clin Neurophys 78:215-21.
26. Mills PB, Struys E, Jakobs C (2006) Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med 12:307-9.
27. Naasan G, Yabroudi M, Rahi A, Mikati MA (2009) Electroencephalographic changes in pyridoxine-dependant epilepsy: new observations. Epileptic Disord 11:293-300.
28. Nabbout R, Soufflet C, Plouin P, Dulac O (1999) Pyridoxine-dependent epilepsy: a suggestive electroclinical pattern. Arch Dis Child Fetal Neonatal Ed 81:F125-9.
29. Plecko B, Stöckler-Ipsiroglu S, Paschke E, et al. (2000) Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy. Ann Neurol 48:121-5.
30. Plecko B, Hikel C, Korenke G-C, et al. (2005) Pipecolic acid as a diagnostic marker of pyridoxine-dependent epilepsy. Neuropediatrics 36:200-5.
31. Plecko B, Paul K, Paschke E, et al. (2007) Biochemical and molecular characterization of 18 patients with pyridoxine-dependent epilepsy and mutations of the antiquitin (ALDH7A1) gene. Hum Mutat 28:19-26.
32. Rankin PM, Harrison S, Chong WK, Boyd S, Aylett SE (2007) Pyridoxine-dependent seizures: a family phenotype that leads to severe cognitive deficits, regardless of treatment regime. Dev Med Child Neurol 49:300-5.
33. Sadilkova K, Gospe, SM, Hahn SH Jr (2009) Simultaneous determination of alpha-aminoadipic semialdehyde, piperideine-6-carboxylate and pipecolic acid by LC-MS/MS for pyridoxinedependent seizures and folinic acid-responsive seizures. J Neurosci Methods 184:136-41.
34. Salomons GS, Bok LA, Struys EA, et al. (2007) An intriguing “silent” mutation and a founder effect in antiquitin (ALDH7A1). Ann Neurol 62:414-18.
35. Schaumburg H, Kaplan J, Windebank A, et al. (1983) Sensory neuropathy from pyridoxine abuse: a new megavitamin syndrome. N Eng J Med 309:445-48.
36. Shih JJ, Kornblum H, Shewmon DA (1996) Global brain dysfunction in an infant with pyridoxine dependency: evaluation with EEG, evoked potentials, MRI, and PET. Neurology 47:824-6.